Searched for
HIV DRUG USFDA NOD
Sell or Hold: Citi maintains buy on Cipla; Motilal Oswal recommends buy on RIL post AGMBrokerages remain bullish on Cipla and Reliance Industries, citing strong growth drivers and attractive valuations. Citi highlights regulat...- US strike on vessel in Caribbean Sea kills 2, leaves 6 survivorsThe U.S. military conducted another strike on a suspected drug boat in the eastern Pacific, resulting in two deaths and six survivors. This...
- 16 fixed-dose combination drugs banned in India: Check full list hereFixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- SBI Funds Management gets Sebi nod for IPOSBI Funds Management, India's largest mutual fund house, has secured SEBI's nod for its upcoming Initial Public Offering, expected to launc...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observationsJubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...
- Who is Bobby Charles? Former Bush administration official holds lead to win Maine GOP governor primary after ranked-choice runoffBobby Charles has won Maine's Republican gubernatorial primary. He secured victory after ranked-choice voting runoffs. Charles is an attorn...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...
- API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
- Firmly committed to building a drug-free Manipur, says CM Yumnam Khemchand SinghManipur is intensifying its fight against drugs. Chief Minister Yumnam Khemchand Singh chaired a meeting to boost intelligence sharing and ...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Centre mandates prescription for syrup-based medicinesChemists must now have a doctor's prescription to sell cough syrups. The government has changed the Drugs Rules, 1945. This stops over-the-...
- Govt ends over-the-counter sales of all 'syrups'; mandates doctor's prescription for purchaseThe Union Ministry of Health and Family Welfare has mandated that all syrups, including cough syrups, are now prescription-only. This new r...
- India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
Load More
